Chemoinformaics analysis of ISOARTEMISIA-KETONE
| Molecular Weight | 152.237 | nRot | 3 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 3 |
| Exact Molecular Weight | 152.12 | nRing | 0 |
| Solubility: LogS | -2.913 | nHRing | 0 |
| Solubility: LogP | 2.827 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 0 | BPOL | 16.9193 |
| QED | 0.449 |
| Synth | 3.332 |
| Natural Product Likeliness | 1.646 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.134 |
| Pgp-sub | 0.002 |
| HIA | 0.007 |
| CACO-2 | -4.475 |
| MDCK | 0.0000259 |
| BBB | 0.287 |
| PPB | 0.777999 |
| VDSS | 1.447 |
| FU | 0.300268 |
| CYP1A2-inh | 0.394 |
| CYP1A2-sub | 0.779 |
| CYP2c19-inh | 0.476 |
| CYP2c19-sub | 0.913 |
| CYP2c9-inh | 0.11 |
| CYP2c9-sub | 0.565 |
| CYP2d6-inh | 0.254 |
| CYP2d6-sub | 0.309 |
| CYP3a4-inh | 0.074 |
| CYP3a4-sub | 0.549 |
| CL | 1.495 |
| T12 | 0.545 |
| hERG | 0.009 |
| Ames | 0.006 |
| ROA | 0.048 |
| SkinSen | 0.78 |
| Carcinogencity | 0.4 |
| EI | 0.988 |
| Respiratory | 0.788 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.938989 |